NSETrading Window28 Sept 2026 · 28 Sept 2026, 01:00 pm

Trading Window

Dr. Agarwal's Health Care Limited · AGARWALEYE

✦ AI SummaryResults

Dr. Agarwal's Health Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, due to the finalization and publication of the Unaudited Financial Results for the quarter and half year ending September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Dr. Agarwal's Health Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

DRAGARWALS_28092026130020_AHCL_TW_CLOSURE_SE.pdf

pdf

Download →
View document text
Ref: AHCL/2026-27/C042 September 28, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No C/1, “G” Block, Dalal Street, Bandra-Kurla Complex Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 544350 Symbol: AGARWALEYE Dear Sir / Madam, Sub: Closure of Trading Window This is to inform that pursuant to Dr. Agarwal’s Health Care Limited (‘the Company’) Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company shall remain closed for all the Designated Persons and their Immediate Relatives with effect from September 30, 2026. The Trading Window closure is being implemented in view of the finalization and publication of the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ending September 30, 2026. The Trading Window shall reopen after the expiry of 48 hours from the announcement of the aforesaid Financial Results by the Company, duly approved by the Board of Directors at their meeting, the details of which shall be communicated in the due course. This information can also be accessed on the website of the Company at: www.dragarwals.co.in We request you to kindly take the above on record. Thanking you, For Dr. Agarwal’s Health Care Limited Thanikainathan Arumugam Company Secretary and Compliance Officer